X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1489) 1489
Newspaper Article (580) 580
Book Review (375) 375
Publication (196) 196
Newsletter (182) 182
Trade Publication Article (52) 52
Magazine Article (47) 47
Book Chapter (24) 24
Web Resource (17) 17
Conference Proceeding (13) 13
Government Document (9) 9
Book / eBook (6) 6
Report (3) 3
Transcript (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ebola virus (1596) 1596
index medicus (1090) 1090
vaccines (904) 904
humans (881) 881
epidemics (587) 587
viruses (581) 581
animals (558) 558
ebola virus infections (553) 553
infectious diseases (478) 478
health aspects (420) 420
medical research (362) 362
virus diseases (335) 335
public health (323) 323
infections (322) 322
virology (315) 315
hemorrhagic fever, ebola - prevention & control (303) 303
immunology (287) 287
ebola (282) 282
research (276) 276
clinical trials (261) 261
infection (251) 251
disease (236) 236
hemorrhagic fever, ebola - epidemiology (231) 231
microbiology (229) 229
hemorrhagic-fever (216) 216
ebolavirus - immunology (211) 211
proteins (204) 204
nonhuman-primates (199) 199
article (194) 194
studies (185) 185
hemorrhagic fever, ebola - virology (181) 181
female (180) 180
analysis (177) 177
prevention (170) 170
fever (168) 168
medicine, experimental (166) 166
mice (165) 165
hemorrhagic fever, ebola - immunology (160) 160
vaccination (155) 155
hemorrhagic fever, ebola - drug therapy (147) 147
medicine, research & experimental (147) 147
immunization (146) 146
mortality (145) 145
antiviral agents (143) 143
pharmaceutical industry (140) 140
vaccine (140) 140
pharmacology & pharmacy (139) 139
disease outbreaks (137) 137
hemorrhagic fever (137) 137
ebola-virus (136) 136
viral diseases (136) 136
care and treatment (135) 135
medicine (135) 135
male (134) 134
glycoprotein (129) 129
hemorrhagic fever, ebola - therapy (128) 128
marburg virus disease (124) 124
outbreaks (124) 124
immunoglobulins (123) 123
antiviral agents - therapeutic use (120) 120
disease models, animal (120) 120
influenza (119) 119
ebolavirus - genetics (118) 118
multidisciplinary sciences (116) 116
laboratories (115) 115
antibodies (113) 113
zika virus (113) 113
ebolavirus (112) 112
filovirus (112) 112
glycoproteins (112) 112
pathogenesis (112) 112
biology (108) 108
epidemiology (105) 105
marburg virus (104) 104
medicine, general & internal (104) 104
antigens (103) 103
ebolavirus - pathogenicity (103) 103
pathogens (102) 102
ebolavirus - drug effects (100) 100
research article (100) 100
ebolavirus - physiology (99) 99
primates (99) 99
research & development--r&d (93) 93
antiviral agents - pharmacology (90) 90
immunotherapy (90) 90
outbreak (90) 90
abridged index medicus (88) 88
ebola vaccines - immunology (88) 88
monoclonal antibodies (88) 88
viral infections (86) 86
disease control (85) 85
product development (84) 84
dendritic cells (83) 83
parasitology (79) 79
global health (78) 78
antibodies, viral - immunology (77) 77
fatalities (77) 77
africa, western - epidemiology (76) 76
protection (75) 75
biotechnology & applied microbiology (74) 74
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2371) 2371
French (9) 9
German (2) 2
Japanese (2) 2
Spanish (2) 2
Chinese (1) 1
Icelandic (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vaccine, ISSN 0264-410X, 09/2017, Volume 35, Issue 38, pp. 5081 - 5088
Journal Article
Journal Article
Science, ISSN 0036-8075, 03/2016, Volume 351, Issue 6277, pp. 1078 - 1083
Journal Article
Nature Medicine, ISSN 1078-8956, 09/2010, Volume 16, Issue 9, pp. 991 - 994
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9964, pp. 214 - 215
  The original plan for the trial, aired by researchers from the US National Institutes of Health (NIH) at the last meeting in October, has been modified to... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Liberia | Clinical Trials, Phase III as Topic | World Health Organization | Hemorrhagic Fever, Ebola - prevention & control | Guinea | Humans | Ebola Vaccines - therapeutic use | Sierra Leone | Clinical trials | Vaccines | Ebola virus | Epidemics | Adenoviruses | Public health
Journal Article
Trends in Microbiology, ISSN 0966-842X, 2014, Volume 23, Issue 2, pp. 65 - 66
While several impeding factors have limited Ebola vaccine development, the current epidemic has provided a surge which may lead to a record pace for a vaccine... 
Internal Medicine | vaccine | immune correlates | FDA clinical trial | Ebola | durable immunity | Durable immunity | Vaccine | Immune correlates | IMMUNITY | VIRUS | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROBIOLOGY | Ebola Vaccines - therapeutic use | Primates | Ebola Vaccines - immunology | Animals | Hemorrhagic Fever, Ebola - prevention & control | Humans | Vaccines | Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 03/2015, Volume 313, Issue 12, pp. 1221 - 1222
Geisbert talks about ebola virus which is among the most deadly pathogens, with case fatality rates of up to 90%. Ebola virus is categorized as a tier 1... 
NONHUMAN-PRIMATES | MEDICINE, GENERAL & INTERNAL | Ebola Vaccines - therapeutic use | Post-Exposure Prophylaxis | Male | Hemorrhagic Fever, Ebola - prevention & control | Humans | Needlestick Injuries - complications | Ebola virus | Pathogens | Emergency medical care | Vaccines | Casualties | Index Medicus | Abridged Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 09/2014, Volume 312, Issue 11, pp. 1095 - 1096
Journal Article
Journal Article